BackPharmGen Science Overview

PharmGen Science Current Assets

Track PharmGen Science's current assets ($92B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$92.00B
↓ 2.60% YoYΔ $-2.46B vs prior year quarter

Peer trimmed avg / median

Loading

PharmGen Science Current Assets History

Loading

PharmGen Science vs. peers: Current Assets Comparison

Loading

PharmGen Science Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PharmGen Science (004720.KS) FAQ

PharmGen Science's current assets stands at $92B as of June 2026. That compares with $94B in the prior-year period — down 2.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

PharmGen Science reported $92B in current assets versus $94B a year earlier — a 2.6% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $94B in the prior-year period — down 2.6% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how PharmGen Science's current assets evolved across reporting periods, while the comparison chart places 004720.KS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.